NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

AdAlta Limited (AU: 1AD)

 
1AD Technical Analysis
5
As on 22nd Nov 2024 1AD STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.02 & Strong Sell for SHORT-TERM with Stoploss of 0.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

1ADSTOCK Price

Open 0.02 Change Price %
High 0.02 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.00 0.00
Volume N/A 1 Year 0.00 0.00
52 Week High 0.03 | 52 Week Low 0.02
 
AU Australia Most Active Stocks
OVT 0.02 %
SYA 0.03 0.00%
PLS 2.61 -6.79%
TMK 0.00 %
ROG 0.01 0.00%
FAU 0.00 %
FFG 0.02 0.00%
RSG 0.40 0.00%
PEN 0.06 0.00%
IMU 0.04 0.00%
 
AU Australia Top Gainers Stocks
APV 0.02 100.00%
RFT 0.02 100.00%
PCL 0.02 100.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
ACW 0.03 50.00%
 
AU Australia Top Losers Stocks
FIN 0.00 -100.00%
LML 0.00 -100.00%
LML 0.00 -100.00%
BMO 0.00 -100.00%
BMO 0.00 -100.00%
BMO 0.00 -100.00%
GRL 0.01 -50.00%
GRL 0.01 -50.00%
RCP 0.02 -33.33%
RCP 0.02 -33.33%
 
 
1AD
Daily Charts
1AD
Intraday Charts
Whats New @
Bazaartrend
1AD
Free Analysis
 
1AD Important Levels Intraday
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
 
1AD Forecast November 2024
4th UP Forecast0.02
3rd UP Forecast0.02
2nd UP Forecast0.02
1st UP Forecast0.02
1st DOWN Forecast0.02
2nd DOWN Forecast0.02
3rd DOWN Forecast0.02
4th DOWN Forecast0.02
 
1AD Weekly Forecast
4th UP Forecast0.04
3rd UP Forecast0.03
2nd UP Forecast0.03
1st UP Forecast0.03
1st DOWN Forecast0.01
2nd DOWN Forecast0.01
3rd DOWN Forecast0.01
4th DOWN Forecast0.00
 
1AD Forecast2024
4th UP Forecast0.08
3rd UP Forecast0.06
2nd UP Forecast0.05
1st UP Forecast0.04
1st DOWN Forecast0
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.02
4th DOWN Forecast-0.04
 
 
1AD Other Details
Segment EQ
Market Capital 22066200.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
1AD Address
1AD
 
1AD Latest News
 
Your Comments and Response on AdAlta Limited
 
1AD Business Profile
AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is based in Bundoora, Australia. Address: 2 Park Drive, Bundoora, VIC, Australia, 3083
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service